MondegarAI
Whitefort Capital Management, LP

Q1 2025 · 13F-HR

Whitefort Capital Management, LPholdings as filed

Filed 2025-05-15 · accession 0001013594-25-000674

$212.5M
Reported value
15
Positions
2025-03-31
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
03879J100ABUSARBUTUS BIOPHARMA CORP$46.4M21.9%13,307,967CommonSOLE
G76279101ROIVROIVANT SCIENCES LTD$34.4M16.2%3,411,000CommonSOLE
46591M109JOYYJOYY INC$31.9M15.0%759,443CommonSOLE
37247D106GNWGENWORTH FINL INC$21.2M9.96%2,986,960CommonSOLE
53635D202LQDALIQUIDIA CORPORATION$15.5M7.29%1,050,180CommonSOLE
68375NAG8OPK 3.75 01/15/29OPKO HEALTH INC$15.1M7.10%9,350,000CommonSOLE
127537207CDZICADIZ INC$10.9M5.13%3,719,951CommonSOLE
68218J103OABIOMNIAB INC$9.4M4.42%3,914,896CommonSOLE
Y27183600GSLGLOBAL SHIP LEASE INC NEW$8.4M3.98%369,768CommonSOLE
404139AG2VATE 7.5 08/01/26 *INNOVATE CORP$7.1M3.35%12,218,000CommonSOLE
45784J303VATEINNOVATE CORP$5.8M2.74%743,000CommonSOLE
78573NAE2SABHLD 4 04/15/25SABRE GLBL INC$5.0M2.34%5,000,000CommonSOLE
G5753U1124OWAMAIDEN HOLDINGS LTD$1.1M0.54%1,997,005CommonSOLE
65345N114NNAVWNEXTNAV INC$207,9620.10%47,264CommonSOLE
896438504TRIBTRINITY BIOTECH PLC$46,6840.02%81,902CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.